Viva Biotech Holdings Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	904.45	941.58	1,036	678.57	800.95	2,308
Trading Asset Securities	-	-	-	-	-	49.5
Cash & Short-Term Investments	904.45	941.58	1,036	678.57	800.95	2,358
Cash Growth	-12.68%	-9.14%	52.72%	-15.28%	-66.03%	152.53%
Accounts Receivable	305.75	420.46	407.41	445.97	429.7	320.51
Other Receivables	-	61.24	136.13	59.41	102.2	82.56
Receivables	305.75	481.7	543.53	505.38	531.9	403.07
Inventory	317.07	272.7	259.71	326.03	231.72	164.75
Prepaid Expenses	-	8.31	5.95	7.94	7.26	5.93
Other Current Assets	218.83	172.31	185.41	420.88	411.95	419.85
Total Current Assets	1,746	1,877	2,031	1,939	1,984	3,352
Property, Plant & Equipment	1,572	1,597	1,655	1,937	1,724	737.01
Long-Term Investments	982.64	988.55	1,038	1,047	1,247	924.53
Goodwill	2,156	2,156	2,156	2,156	2,156	1,848
Other Intangible Assets	338.83	366.05	420.67	476.06	531.44	469.46
Long-Term Accounts Receivable	3.27	3.51	5.25	6.43	16.12	15.38
Long-Term Deferred Tax Assets	34.15	21.8	21.19	18.18	7.63	9.94
Other Long-Term Assets	49.02	40.36	122.76	340.97	378.73	798.49
Total Assets	6,883	7,051	7,450	7,921	8,045	8,154
Accounts Payable	181.26	309.36	245.76	326.13	281.05	295.7
Accrued Expenses	83.63	97.96	133.35	140.37	105.85	147.68
Short-Term Debt	314.59	261.31	538.03	373.94	228.9	25
Current Portion of Long-Term Debt	286.38	288.08	411.48	1,540	4.15	130.55
Current Portion of Leases	2.67	3.09	2.93	2.27	5.69	11.41
Current Income Taxes Payable	19.65	28.87	32.02	41.63	41.31	15.76
Current Unearned Revenue	44.23	50.98	36.42	44.24	50.01	13.39
Other Current Liabilities	59.28	87.01	134.19	204	209.64	96.18
Total Current Liabilities	991.68	1,127	1,534	2,673	926.6	735.67
Long-Term Debt	528.06	705.92	922.01	880.96	2,388	2,799
Long-Term Leases	24.53	25.65	28.76	25.8	27.77	3.91
Long-Term Unearned Revenue	30.47	33	55.02	73.12	75.27	22.71
Long-Term Deferred Tax Liabilities	71.99	73.85	69.19	92.2	117.73	119.18
Other Long-Term Liabilities	1,329	1,269	1,153	571.5	595.85	717.14
Total Liabilities	2,975	3,234	3,762	4,316	4,131	4,397
Common Stock	0.36	0.37	0.37	0.33	0.33	0.32
Additional Paid-In Capital	3,841	3,874	3,874	3,637	3,637	3,651
Retained Earnings	-5.41	-127.21	-294.51	-178.4	350.08	62.53
Treasury Stock	-129.13	-157.67	-134.65	-134.65	-134.65	-52.68
Comprehensive Income & Other	185.95	212.73	242.54	280.48	60.65	95.9
Total Common Equity	3,893	3,802	3,688	3,605	3,913	3,757
Minority Interest	14.68	13.84	-	-	-	-
Shareholders' Equity	3,907	3,816	3,688	3,605	3,913	3,757
Total Liabilities & Equity	6,883	7,051	7,450	7,921	8,045	8,154
Total Debt	1,156	1,284	1,903	2,823	2,655	2,970
Net Cash (Debt)	-251.77	-342.47	-866.9	-2,144	-1,854	-611.56
Net Cash Per Share	-0.08	-0.12	-0.43	-1.12	-0.94	-0.39
Filing Date Shares Outstanding	2,110	2,113	2,142	1,915	1,915	1,912
Total Common Shares Outstanding	2,110	2,113	2,142	1,915	1,915	1,912
Working Capital	754.42	749.94	496.74	-733.75	1,057	2,616
Book Value Per Share	1.85	1.80	1.72	1.88	2.04	1.97
Tangible Book Value	1,398	1,280	1,111	972.23	1,225	1,440
Tangible Book Value Per Share	0.66	0.61	0.52	0.51	0.64	0.75
Buildings	-	759.47	558.65	553.56	293.19	107.01
Machinery	-	926.64	805.36	703.13	552.49	339.45
Construction In Progress	-	109.54	338.48	469.88	542.03	132.07
Leasehold Improvements	-	26.29	26.29	26.29	37.07	33.64
Order Backlog	-	-	-	-	965	607

Source: S&P Global Market Intelligence. Standard template. Financial Sources.